Stent and vascular and coronary devices
Stent e dispositivi vascolari e coronarici
Italy · how to bid here →
Your path to submission
- Deadline: 12 November at 17:00 — 39 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA, ITA.
- Collect your evidence — use the eligibility analysis above: it lists the requirements and, for known certificates, how to get them.
Clement What the numbers say about this buyer
- The award came in at a median 44% of the estimated value (31 awards with both estimate and value) — pricing at the estimate is usually too high here. Country: 67%.n = 31
- 28% of this buyer's awards went to companies that had already won here before (1,335 awards since 2017, spread over 956 companies). 72% went to new names.n = 1,335 awards since 2017
- The median procedure drew just one bid (529 procedures with a bid count); 71% ended with a single bidder. Country: median 1.1 bids.n = 529
- Across 17 procedures with structured selection criteria, this buyer most often required: Trade register enrolment (17 of 17), References: services (14 of 17), Professional register enrolment (9 of 17), Independent environmental certificate (ISO 14001 / EMAS) (7 of 17).n = 17
- Not one of the 1,335 awards with a known winner country has gone to a foreign company so far. National average: 0%.n = 1,335
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 04/10/2026.
Foreign bidders
In Italy, 2,157 contracts went to foreign companies over the last 3 years (of 2,216,733 recorded awards) — mostly from France, Germany, Spain.
What the buyer is looking for
OPEN PROCEDURE FOR THE RELIANCE OF THE SUPPLY OF STENTS AND VASCULAR AND CORONARIC DEVICES FOR THE NEEDS OF AA.SS.RR. OF THE CAMPANIA REGION AND SARDINIA REGION Lots: Device for the percutaneous closure of interatrial defects (DIA) and patent foramen ovale (PFO) with screw release system, self-expandable, recaptureable and repositionable, consisting of two discs in nitinol.; Device for the percutaneous closure of the interatrial defects (DIA) and the patent foramen ovale (PFO) of PFO with non-screw release system, (eg caliper, biotome or cord) self-expandable, recaptureable and repositionable, allowing greater angular flexibility.; Single-body percutaneous system for obliteration of the left earpiece.; Percutaneous double disc system for obliteration of the left earpiece.; System for the percutaneous closure of peri-valvular leaks (mitral, aortic and tricuspidal).; Device for the…
Show full description
… closure of the self-expanding Interventricular Defect (DIV); Renal denervation system: radiofrequency and/or ultrasound.; Balloon expandable aortic valve: aortic valve bioprosthesis on metal support for expandable transcatheter implant with balloon.; Self expandable aortic valve: aortic valve bioprosthesis on metal support for self-expanding transcatheter implant.; Percutaneous system for the treatment of mitral insufficiency: system for the treatment of mitral insufficiency using a dedicated device.; Percutaneous system for mitral anuloplasty: anuloplasty system for mitral valve reconstruction by trans-septic trans-venous procedure; Percutaneous system for the treatment of tricuspid insufficiency: system for trans-catheter treatment using a dedicated device.; Percutaneous system for the combined treatment of mitral and tricuspid insufficiency.; Percutaneous mitral valve: Valvular bioprosthesis on metal support for trans-catheter implantation.; Percutaneous tricuspid valve: Valvular bioprosthesis on metal support for trans-catheter implantation.; Percutaneous implant pulmonary valve: Valvular bioprosthesis on metal support for transcatheter treatment of pulmonary valve dysfunction.; Closing system for large-caliber vascular accesses, usable in structural interventional cardiology: dedicated system equipped with PLGA and collagen anchor; Device for femoral hemostasis using suture thread.; Brain protection system: device usable during percutaneous aortic valve implantation procedure for anti-embolic protection, capture and recovery of embolic material.; Transeptal puncture needle: Brockenbrough type needle in stainless steel equipped with insertion stiletto, removable proximal knob for inspection and washing.; System for transectal puncture in the presence of hostile septa; Adjustable transeptal puncture needle: Brockenbrough type needle in stainless steel equipped with insertion stiletto, removable proximal knob for inspection and washing.; Balloon with long shaft for radial access femoral iliac axis: Peripheral balloon OTW catheter for the treatment of de novo and/or iatrogenic lesions of the iliac-femoral axis; Balloon with shaft of different sizes for iliac-femoral axis from femoral access.; Peripheral stents for iliac axis: self-expanding release system.; Peripheral stents for iliac axis: expandable ballon release system.; Peripheral stents by femoral-popliteal axis: self-expanding release system without drug release.; Peripheral stents by femoral-popliteal axis: self-expanding drug release system.; Peripheral stents by femoral-popliteal axis: expandable balloon release system without drug release.; Peripheral stents by femoral-popliteal axis: Expandable drug-release balloon release system.; Sten
What you must prove — eligibility criteria
From the notice of the same procedure on TED — Tenders Electronic Daily.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| FATICONI - SOCIETA' PER AZIONI | 15 | 2024–2026 |
| SANOFI S.R.L. | 10 | 2024–2026 |
| ATHENA SRL | 9 | 2024–2026 |
| MAGGIOLI S.P.A. | 8 | 2024–2025 |
| POLISTE SRL SB | 7 | 2024–2026 |